| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.61.8_SUPPL_4.S27 |
| P953 | full work available at URL | https://www.neurology.org/doi/full/10.1212/WNL.61.8_suppl_4.S27 |
| P698 | PubMed publication ID | 14581655 |
| P2093 | author name string | Susan Abu-Shakra | |
| Roger Yates | |||
| Nick Syrett | |||
| P2860 | cites work | Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials | Q30618471 |
| Integrating the triptans into clinical practice | Q34667996 | ||
| A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine | Q39431252 | ||
| Sumatriptan. An updated review of its use in migraine | Q39447453 | ||
| Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group | Q39452008 | ||
| Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers | Q44202476 | ||
| Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers | Q44202479 | ||
| Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet | Q44492681 | ||
| Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial | Q44551412 | ||
| Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group | Q73884479 | ||
| Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients | Q78961225 | ||
| P433 | issue | 8 Suppl 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | S27-30 | |
| P577 | publication date | 2003-10-01 | |
| 2003-10-28 | |||
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Zolmitriptan nasal spray: advances in migraine treatment | |
| P478 | volume | 61 |
| Q37785210 | Acute treatment of migraine |
| Q37008907 | Clinical pharmacology of the serotonin receptor agonist, zolmitriptan |
| Q46802574 | Fabrication of molecularly imprinted hybrid monoliths via a room temperature ionic liquid-mediated nonhydrolytic sol-gel route for chiral separation of zolmitriptan by capillary electrochromatography |
| Q36133893 | Non-oral formulations of triptans and their use in acute migraine |
| Q46377572 | Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine |
Search more.